Matt Pierce
Investment Director
Healthcare Ventures
Matt joined Downing in 2018, having qualified as a chartered accountant at Deloitte focusing on life science clients. He also worked at Berenberg in the healthcare equity research team. Matt is responsible for originating, transacting and monitoring investment opportunities for Downing's life sciences and healthcare investments. Matt holds a degree in biotechnology from the University of Edinburgh.
Downing LLP does not provide advice or make personal recommendations and investors are strongly urged to seek independent advice before investing. Investments offered on this website carry a higher risk than many other types of investment and prospective investors should be aware that capital is at risk and the value of their investment may go down as well as up. Any investment should only be made on the basis of the relevant product literature and your attention is drawn to the risk, fees and taxation factors contained therein. Tax treatment depends on individual circumstances of each investor and may be subject to change in the future. Past performance is not a reliable indicator of future performance. Downing LLP is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 545025). Registered in England No. OC341575. Registered Office: St Magnus House, 3 Lower Thames Street, London EC3R 6HD.
VAT Number: 112 940 149
